Rectal cancer: Assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI

Clinical Cancer Research

Volumn 22, Issue 21, 2016, Pages 5256-5264

  Nie, Ke ^a   Shi, Liming ^b   Chen, Qin ^b   Hu, Xi ^b   Jabbour, Salma K ^a   Yue, Ning ^a   Niu, Tianye ^b,c   Sun, Xiaonan ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; GADOLINIUM PENTETATE; OXALIPLATIN; CONTRAST MEDIUM;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LOCALLY ADVANCED RECTAL CANCER; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION MEASUREMENT; RADIATION RESPONSE; RADIOMICS; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; TREATMENT OUTCOME; TUMOR REGRESSION; VALIDATION PROCESS; VOXEL BASED MORPHOMETRY; CHEMORADIOTHERAPY; METABOLISM; NEOADJUVANT THERAPY; PATHOLOGY; PROCEDURES; RECTUM TUMOR; REPRODUCIBILITY;

AREA UNDER CURVE; CHEMORADIOTHERAPY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TREATMENT OUTCOME;

EID: 84994560182     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-2997     Document Type: Article

References (40)

1. van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon and rectum. Eur J Cancer 2014;50:1. e1-1.e34.
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
3. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010;11:835-44.
4. Sanghera P, Wong DW, McConkey CC, Geh JI, Hartley A. Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol (R Coll Radiol) 2008;20: 176-83.
5. Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006;10:1319-28.
6. Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011;29:4633-40.
7. Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008;15:712-20.
8. Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, et al. Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18) F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys 2010;77:392-9.
9. Engelen SM, Beets-Tan RG, Lahaye MJ, Lammering G, Jansen RL, van Dam RM, et al. MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision. Dis Colon Rectum 2010;53:979-86.
10. Intven M, Reerink O, Philippens ME. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation. J Magn Reson Imaging 2015;41:1646-53.
11. Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, et al. Diffusion weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011;18:2224-31.
12. Intven M, Reerink O, Philippens ME. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neoadjuvant radiochemotherapy. Strahlenther Onkol 2012;189:117-22.
13. Oberholzer K, Junginger T, Heintz AR et al Cancer : MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvement. J Magn Reson Imaging 2012;36:658-63.
14. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones RR et al carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR AM J Roentgenol 2007;188:442-51.
15. Aiba T, Uehara K, Nihashi T, Tsuzuki T, Yatsuya H, Yoshioka Y, et al. MRI and FDG-PET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer. Ann Surg Oncol 2014;21:1801-8.
16. Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiol 2009;253: 116-25.
17. Lambregts D, Beets G, Maas M, Curvo-Semedo L, Kessels AG, Thywissen T, et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol 2011;21:2567-74.
18. Rao SX, Zeng MS, Chen CZ, Li RC, Zhang SJ, Xu JM, et al. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008;65:299-303.
19. Lim JS, Kim D, Baek SE, Myoung S, Choi J, Shin SJ et al., Perfusion MRI for the prediction of treatment response after preoperative chemotherapy in locally advanced rectal cancer. Eur Radiol 2012;22:1693-700.
20. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Carducci MA, et al. (eds.). American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. New York: Springer; 2009.
21. Cassidy J, Saltz L, Twelves C, Van Cutsem E, Hoff P, Kang Y, et al. et al., Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: ameta-analysis of individual data from 6171 patients. Ann Oncol 2011;22:2604-9.
22. Haralick RM. Statistical and structural approaches to texture. Proc IEEE 1979;67:786-804.
23. Petrillo A, Fusco R, Petrillo M, Granata V, Sansone M, Avallone A, et al. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol 2015;25:1935-45.
24. Lin B, Lin G, Liu X, Ma J, Wang X, Lin F, et al. et al., Application of backpropagation artificial neural network and curve estimation in pharmacokinetics of losartan in rabbit. Int J Clin Exp Med 2015;8:22353-58.
25. Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010;254:170-8.
26. Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2012;82:863-70.
27. Jacobs L, Intven M, van Lelyveld N, Philippens M, Burbach M, Seldenrijk K, et al. Diffusion-weighted MRI for early prediction of treatment response on preoperative chemoradiotherapy for patients with locally advanced rectal cancer: a feasibility study. Ann Surg 2015. [Epub ahead of print]
28. Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, et al. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation. World J Gastroenterol 2013;19: 5520-7.
29. Kim SH, Lee JY, Lee JM, Han JK, Choi BI. Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 2011;21:987-95.
30. DeVries AF, Kremser C, Hein PA, Griebel J, Krezcy A, Ofner D, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:958-965.
31. Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006;41:618-23.
32. Tong T, Sun Y, Gollub MJ, Peng W, Cai S, Zhang Z, et al. Dynamic contrastenhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. J Magn Reson Imaging 2015;42:673-80.
33. Intven M, Monninkhof EM, Reerink O, Philippens ME. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neoadjuvant chemoradiation in locally advanced rectal cancer. Acta Oncol 2015;27:1-8.
34. Endrich B, Vaupel P. The role of microcirculation in the treatment of malignant tumours: facts and fiction. In: Molls M, Vaupel P, editors. Blood perfusion and microenvironment of human tumors. Berlin: Springer; 1998. p 19-39.
35. Höckel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, et al. Intratumoral pO2predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
36. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. The Fourteenth International Joint Conference on Artificial Intelligence Morgan Kaufmann, San Mateo 1995: 1137-43.
37. Breiman L, Spector P. Submodel selection and evaluation in regression. The X-Random Case. Int Stat Rev 1992;60-:291-319.
38. McLaren CE, Chen WP, Nie K, Su MY. Prediction of malignant breast lesions from MRI features: a comparison of artificial neural network and logistic regression techniques. Acad Radiol 2009;16:842-51.
39. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)- weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32.
40. Lankester KJ, Taylor JN, Stirling JJ, Boxall J, d'Arcy JA, Collins DJ, et al. Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. JMag Reson Imaging 2007;25:796-805.